Studies have shown that the decreased FOXO1 activity reduces the transcription of its target gene PGC1-α in MCs, thereby inhibiting mitochondrial biogenesis and promoting the progression of DKD 30. The gene discussed is PPARGC1A; the disease is diabetic kidney disease.